Role of Arginase 1 from Myeloid Cells in Th2-Dominated Lung Inflammation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Barron, Luke ^a   Smith, Amber M ^b   El Kasmi, Karim C ^b,g   Qualls, Joseph E ^b,h   Huang, Xiaozhu ^c   Cheever, Allen ^d   Borthwick, Lee A ^e   Wilson, Mark S ^f   Murray, Peter J ^b   Wynn, Thomas A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^g Children's Hospital Colorado   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; BONE MARROW CELL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LUNG GRANULOMA; MACROPHAGE; MOUSE; MUCUS SECRETION; NONHUMAN; PNEUMONIA; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SCHISTOSOMA MANSONI; TH2 CELL;

ANIMALS; ANTIGENS, HELMINTH; ARGINASE; ASPERGILLUS; GENE EXPRESSION; GRANULOMA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; MYELOID CELLS; OVALBUMIN; PNEUMONIA; SCHISTOSOMA MANSONI; TH2 CELLS;

MUS;

EID: 84876586281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061961     Document Type: Article

References (51)

1. Ramalingam TR, Reiman RM, Wynn TA, (2005) Exploiting worm and allergy models to understand Th2 cytokine biology. Curr Opin Allergy Clin Immunol 5: 392-398.
2. Wilson MS, Wynn TA, (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121.
3. Gordon S, Martinez FO, (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
4. Wynn TA, Barron L, (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30: 245-257.
5. Murray PJ, Wynn TA, (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
6. Moreira AP, Hogaboam CM, (2011) Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution. J Interferon Cytokine Res 31: 485-491.
7. Nguyen TH, Casale TB, (2011) Immune modulation for treatment of allergic disease. Immunol Rev 242: 258-271.
8. Di Costanzo L, Sabio G, Mora A, Rodriguez PC, Ochoa AC, et al. (2005) Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc Natl Acad Sci U S A 102: 13058-13063.
9. Morris SM Jr, (2009) Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 157: 922-930.
10. Morris SM Jr, (2007) Arginine metabolism: boundaries of our knowledge. J Nutr 137: 1602S-1609S.
11. Murray PJ, Wynn TA, (2011) Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 89: 557-563.
12. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, et al. (2003) Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 111: 1863-1874.
13. Niese KA, Collier AR, Hajek AR, Cederbaum SD, O'Brien WE, et al. (2009) Bone marrow cell derived arginase I is the major source of allergen-induced lung arginase but is not required for airway hyperresponsiveness, remodeling and lung inflammatory responses in mice. BMC Immunol 10: 33.
14. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA, (2009) Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 296: L911-920.
15. Jacobsen LC, Theilgaard-Monch K, Christensen EI, Borregaard N, (2007) Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood 109: 3084-3087.
16. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, et al. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105: 2549-2556.
17. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, et al. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9: 1399-1406.
18. Qualls JE, Neale G, Smith AM, Koo MS, DeFreitas AA, et al. (2010) Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci Signal 3: ra62.
19. Sandler NG, Mentink-Kane MM, Cheever AW, Wynn TA, (2003) Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171: 3655-3667.
20. Maarsingh H, Zaagsma J, Meurs H, (2009) Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 158: 652-664.
21. Ilies M, Di Costanzo L, Dowling DP, Thorn KJ, Christianson DW, (2011) Binding of alpha,alpha-disubstituted amino acids to arginase suggests new avenues for inhibitor design. J Med Chem 54: 5432-5443.
22. Maarsingh H, Zaagsma J, Meurs H, (2008) Arginine homeostasis in allergic asthma. Eur J Pharmacol 585: 375-384.
23. Maarsingh H, Zuidhof AB, Bos IS, van Duin M, Boucher JL, et al. (2008) Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation. Am J Respir Crit Care Med 178: 565-573.
24. Yang M, Rangasamy D, Matthaei KI, Frew AJ, Zimmmermann N, et al. (2006) Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol 177: 5595-5603.
25. Maarsingh H, Dekkers BG, Zuidhof AB, Bos IS, Menzen MH, et al. (2011) Increased arginase activity contributes to airway remodelling in chronic allergic asthma. Eur Respir J 38: 318-328.
26. Takahashi N, Ogino K, Takemoto K, Hamanishi S, Wang DH, et al. (2010) Direct inhibition of arginase attenuated airway allergic reactions and inflammation in a Dermatophagoides farinae-induced NC/Nga mouse model. Am J Physiol Lung Cell Mol Physiol 299: L17-24.
27. Nieuwenhuizen NE, Kirstein F, Jayakumar J, Emedi B, Hurdayal R, et al. (2012) Allergic airway disease is unaffected by the absence of IL-4Ralpha-dependent alternatively activated macrophages. J Allergy Clin Immunol 130: 743-750 e748.
28. Lewis F (2001) Schistosomiasis. Curr Protoc Immunol Chapter 19: Unit 19 11.
29. Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, et al. (2011) Quantitative assessment of macrophage functions in repair and fibrosis. Curr Protoc Immunol Chapter 14: Unit14 22.
30. Caceres AI, Brackmann M, Elia MD, Bessac BF, del Camino D, et al. (2009) A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A 106: 9099-9104.
31. Gordon ED, Sidhu SS, Wang ZE, Woodruff PG, Yuan S, et al. (2012) A protective role for periostin and TGF-beta in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy 42: 144-155.
32. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, et al. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
33. Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, et al. (2010) Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184: 6438-6446.
34. Thompson RW, Pesce JT, Ramalingam T, Wilson MS, White S, et al. (2008) Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog 4: e1000023.
35. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A, (1994) Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179: 1551-1561.
36. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, et al. (2004) The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157-3166.
37. Taylor JJ, Mohrs M, Pearce EJ, (2006) Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 176: 5839-5847.
38. Pacifico LG, Marinho FA, Fonseca CT, Barsante MM, Pinho V, et al. (2009) Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10. Infect Immun 77: 98-107.
39. Cardoso LS, Oliveira SC, Goes AM, Oliveira RR, Pacifico LG, et al. (2010) Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol 160: 266-274.
40. Kim JO, Kim DH, Chang WS, Hong C, Park SH, et al. (2004) Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J Allergy Clin Immunol 114: 1332-1338.
41. Di Costanzo L, Ilies M, Thorn KJ, Christianson DW, (2010) Inhibition of human arginase I by substrate and product analogues. Arch Biochem Biophys 496: 101-108.
42. Dowling DP, Di Costanzo L, Gennadios HA, Christianson DW, (2008) Evolution of the arginase fold and functional diversity. Cell Mol Life Sci 65: 2039-2055.
43. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K, (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 25: 1101-1104.
44. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, et al. (2001) Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 166: 2173-2177.
45. El-Gayar S, Thuring-Nahler H, Pfeilschifter J, Rollinghoff M, Bogdan C, (2003) Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol 171: 4561-4568.
46. Bogdan C, (2001) Nitric oxide and the immune response. Nat Immunol 2: 907-916.
47. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167: 6533-6544.
48. Rothenberg ME, Doepker MP, Lewkowich IP, Chiaramonte MG, Stringer KF, et al. (2006) Cationic amino acid transporter 2 regulates inflammatory homeostasis in the lung. Proc Natl Acad Sci U S A 103: 14895-14900.
49. Coomes SM, Hubbard LL, Moore BB, (2011) Impaired pulmonary immunity post-bone marrow transplant. Immunol Res 50: 78-86.
50. Bronte V, Zanovello P, (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654.
51. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.